AzTrials
AzTrials

Unsatisfactory or Defective Restoration of ToothMIZE-SNCT01997710

Minimal Invasive Rehabilitation of Tooth Loss in the Posterior Segment (MIZE-S)

A study testing all-ceramic inlay-retained RBFDP and all-ceramic RBFDP in people with Unsatisfactory or Defective Restoration of Tooth, run by University Hospital Heidelberg at 1 site in Germany.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Tooth loss can be addressed by different rehabilitative strategies. Implant-supported crowns and conventional bridges (fixed dental prostheses [FDPs]) are well established treatment alternatives. Implant therapy is sometimes impossible, however, because of patient-related risk factors or economic issues. Read more about this study

Who is it for?
Ages 18 to 89 yearsHealthy volunteers can take part
What is being tested?
all-ceramic inlay-retained RBFDP and all-ceramic RBFDP
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteGermany
Study dates
Oct 2013to Jan 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 89 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • missing second premolar, or first molar, or second molar
  • regular patient of the department of prosthodontics of the university hospital of heidelberg
  • willingness to return for recall examinations on a regular basis
  • written informed consent
  • abutment teeth are vital or sufficiently endodontically treated
  • abutment teeth are periodontally stable
  • abutment teeth have only little or no defects of the hardsubstances

Who cannot join

  • Pregnancy or breastfeeding
  • medically compromised condition not allowing for standard dental treatment
  • Patient is not able to give written informed consent
  • alcohol or drug abuse
  • positive bruxism and parafunctions questionaire
  • Bite-Strip > 2
Show all 16Show fewer
  • Attrition Score > 3
  • deep bite (Angle class II/2)
  • abutment tooth height < 4mm
  • missing canine or first premolar
  • gap size > 18 mm
  • untreated symptomatic periodontal or endodontic lesions
  • abutment tooth mobility > grade I
  • known allergies to materials used in this study
  • poor dental hygiene
  • planned change of residency

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • Department of Prosthodontics, University Hospital Heidelberg, University of Heidelberg

    Heidelberg, Baden-Wurttemberg, 69120

Other trials in Germany

About this study

Official title: Clinical Performance of Two Different Designs of All-ceramic Resin-bonded Fixed Dental Prostheses in the Posterior Segment - a Randomized Controlled Pilot Study.

Tooth loss can be addressed by different rehabilitative strategies. Implant-supported crowns and conventional bridges (fixed dental prostheses [FDPs]) are well established treatment alternatives. Implant therapy is sometimes impossible, however, because of patient-related risk factors or economic issues. In such cases therapy with an FDP requires extensive removal of tooth structure to provide enough space for the restoration and to ensure mechanical retention if the abutment teeth are sound. Alternatives for rehabilitation requiring minor or no preparation of the anchoring teeth are desirable. Resin-bonded bridges meet this demand for minimal invasiveness and have been used clinically successfully. Sometimes, however, patients choose a conventional FDP over a resin-bonded one (RBFDP) for esthetic reasons since the adhesive wings, which are traditionally made of a cobalt-chromium alloy, might be exposed while speaking or smiling or account for a colour change of the abutment teeth. Such patients profit from an all-ceramic RBFDP. Today, the clinical performance of different all-ceramic RBFDP designs has not yet been evaluated under randomized controlled conditions. The aim of this pilot study is to calculate the sample size that allows us to accept the hypothesis that the two designs tested are similar regarding their clinical performance with adequate statistical power.

Being tested
all-ceramic inlay-retained RBFDP, all-ceramic RBFDP

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • all-ceramic inlay-retained RBFDPDevice

    Rehabilitation of tooth loss with an all-ceramic inlay-retained RBFDP

  • all-ceramic RBFDPDevice

    Rehabilitation of tooth loss with an all-ceramic RBFDP

Study groups in NCT01997710
Study groupRoleWhat they receive
all-ceramic inlay-retained RBFDPExperimentalTreatment with an all-ceramic inlay-retained RBFDP
Receives: Device: all-ceramic inlay-retained RBFDP
all-ceramic RBFDPActive comparatorTreatment with an all-ceramic RBFDP
Receives: Device: all-ceramic RBFDP

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Success

    restoration/abutment teeth without intervention according to the Fédération dentaire internationale (FDI) World dental federation criteria

    Measured: 24 months

Secondary outcomes (1)
  1. restoration and antagonist wear

    wear (µm) of areas of interest at restoration and antagonists

    Measured: 12 months, 24 months, 36 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Nov 2013 (estimated)
  2. Study startOct 2013
  3. Primary completionJan 2026 (estimated)
  4. Study completionJan 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01997710
Sponsor's protocol ID
S-083/2013b
Acronym
MIZE-S
Status last verified
Dec 2023
First submitted
18 Nov 2013
Last updated
18 Dec 2023
Results posted
No
Data monitoring committee
Yes

Publications

  • Bomicke W, Rathmann F, Pilz M, Bermejo JL, Waldecker M, Ohlmann B, Rammelsberg P, Zenthofer A. Clinical Performance of Posterior Inlay-Retained and Wing-Retained Monolithic Zirconia Resin-Bonded Fixed Partial Dentures: Stage One Results of a Randomized Controlled Trial. J Prosthodont. 2021 Jun;30(5):384-393. doi: 10.1111/jopr.13258. Epub 2020 Oct 4.

    PubMed 32924240
  • Bomicke W, Rathmann F, Rammelsberg P, Zenthofer A. Three-year performance of inlay-retained or wing-retained zirconia resin-bonded fixed partial dentures - results from a randomized clinical pilot study. J Dent. 2025 Aug;159:105807. doi: 10.1016/j.jdent.2025.105807. Epub 2025 May 6.

    PubMed 40339895

Questions about this trial

What is this clinical trial studying?

A study testing all-ceramic inlay-retained RBFDP and all-ceramic RBFDP in people with Unsatisfactory or Defective Restoration of Tooth, run by University Hospital Heidelberg at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 16 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 18 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Success (time frame: 24 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01997710, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Dec 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in